Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-10 Sale |
2025-01-13 4:04 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram President and CEO |
8,705 | $1.54 | $13,406 | 349,364 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 4:30 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
11,271 | $4.38 | $49,367 | 158,069 (Direct) |
View |
| 2023-01-10 Sale |
2023-01-11 4:08 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
10,917 | $5.24 | $57,205 | 168,917 (Direct) |
View |
| 2022-07-07 Sale |
2022-07-08 4:51 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
17,158 | $30.23 | $518,686 | 192,990 (Direct) |
View |
| 2022-07-06 Sale |
2022-07-07 4:04 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
7,842 | $30.07 | $235,809 | 218,852 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-15 4:27 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $31.07 | $776,733 | 215,990 (Direct) |
View |
| 2022-01-11 Sale |
2022-01-13 4:07 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
4,570 | $48.5 | $221,655 | 146,532 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-12 4:05 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
5,596 | $46.38 | $259,558 | 151,102 (Direct) |
View |
| 2021-12-13 Sale |
2021-12-14 4:18 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $47.66 | $1,191,406 | 217,854 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-14 4:01 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $66.29 | $1,657,257 | 181,896 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-16 4:26 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $89.32 | $2,233,045 | 206,896 (Direct) |
View |
| 2021-03-15 Sale |
2021-03-16 4:05 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $92.35 | $2,308,772 | 111,896 (Direct) |
View |
| 2021-01-08 Sale |
2021-01-12 8:40 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
9,484 | $114.95 | $1,090,140 | 77,727 (Direct) |
View |
| 2020-12-14 Sale |
2020-12-15 4:01 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $97.78 | $2,444,477 | 128,367 (Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 4:02 pm |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $36.28 | $907,024 | 153,367 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-16 Option Award |
2025-01-16 6:36 pm |
N/A 2035-01-15 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram President and CEO |
1,300,000 | $0 | 1,300,000 (Direct) |
View |
| 2024-07-29 Option Award |
2024-07-31 6:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
200,000 | $0 | 358,069 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:09 pm |
N/A 2034-01-31 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-02-06 Option Award |
2023-02-07 4:20 pm |
N/A 2033-02-05 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
450,000 | $0 | 450,000 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-13 4:02 pm |
N/A 2023-01-14 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
423 | $0 | 169,340 (Direct) |
View |
| 2023-01-12 Exercise |
2023-01-13 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
423 | $1.37 | 169,340 (Direct) |
View |
| 2022-07-07 Exercise |
2022-07-08 4:51 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
17,158 | $2.73 | 192,990 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-07 4:04 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
5,842 | $2.73 | 218,852 (Direct) |
View |
| 2022-07-06 Exercise |
2022-07-07 4:04 pm |
N/A 2025-01-05 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
2,000 | $4.84 | 218,852 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-15 4:27 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $0 | 215,990 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-15 4:27 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $2.73 | 215,990 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:38 pm |
N/A 2032-01-24 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram See Remarks |
86,360 | $0 | 232,892 (Direct) |
View |
| 2021-12-13 Exercise |
2021-12-14 4:18 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $0 | 217,854 (Direct) |
View |
| 2021-12-13 Exercise |
2021-12-14 4:18 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
25,000 | $2.73 | 217,854 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-22 5:44 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief R&D Officer |
60,958 | $0 | 156,698 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 4:01 pm |
N/A 2027-01-04 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 181,896 (Direct) |
View |
| 2021-09-13 Exercise |
2021-09-14 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $2.73 | 181,896 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:26 pm |
N/A 2026-01-08 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 206,896 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:26 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
16,156 | $2.9 | 206,896 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-16 4:26 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
8,844 | $2.73 | 206,896 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 4:05 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 111,896 (Direct) |
View |
| 2021-03-15 Exercise |
2021-03-16 4:05 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $2.9 | 111,896 (Direct) |
View |
| 2021-01-20 Option Award |
2021-01-22 6:22 pm |
N/A 2031-01-20 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
24,864 | $0 | 102,591 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 4:01 pm |
N/A 2026-01-07 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 128,367 (Direct) |
View |
| 2020-12-14 Exercise |
2020-12-15 4:01 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $2.9 | 128,367 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:02 pm |
N/A 2021-03-11 |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
25,000 | $0 | 153,367 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
3,076 | $1.69 | 153,367 (Direct) |
View |
| 2020-09-14 Exercise |
2020-09-16 4:02 pm |
N/A N/A |
FATE THERAPEUTICS INC | FATE | Valamehr Bahram Chief Development Officer |
21,924 | $2.9 | 153,367 (Direct) |
View |